| Literature DB >> 29869881 |
Chie Suzuki1,2, Tomoya Uehara1, Naoki Kanazawa1, Shota Wada1, Hiroyuki Suzuki1, Yasushi Arano1.
Abstract
The obstructive renal radioactivity after injection of antibody fragments/constructs labeled with metallic radionuclides would be improved by liberating a radiometal chelate of urinary excretion from the antibody molecules by enzymes on the renal brush border membrane (BBM). A tripeptide GFK sequence was newly evaluated as an enzyme-cleavable linkage and conjugated to a 99mTc chelate of an isonicotinic acid derivative of 2-picolylglycine (99mTc-IPG). 99mTc-IPG-glycine was liberated from 99mTc-IPG-GFK by the enzymes, while 99mTc-IPG-GK (where the tripeptide GFK was substituted with a dipeptide GK) did not. When injected into mice, 99mTc-IPG-GFK-conjugated Fab exhibited lower renal radioactivity levels than directly radioiodinated Fab shortly after injection without reducing the tumor radioactivity levels, due to a release and excretion of 99mTc-IPG-glycine by enzymes present on the renal BBM. These findings would provide insights to develop antibody fragments/constructs labeled with metallic radionuclides of the clinical relevance for improved renal radioactivity levels.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29869881 DOI: 10.1021/acs.jmedchem.8b00198
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446